We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Allstate Finalizes Group Health Divestiture for $1.25 Bn
Read MoreHide Full Article
Key Takeaways
ALL closed the sale of its Group Health business to Nationwide, making a roughly $500 million book gain.
The move is part of ALL's $3.25 billion divestiture plan to exit Health and Benefits operations.
ALL aims to boost focus on core operations like Property-Liability and Protection Services units.
The Allstate Corporation (ALL - Free Report) recently closed the sale of its Group Health business to Nationwide for a total consideration of $1.25 billion. ALL initially announced its intention to divest this business in January 2025, and as anticipated, successfully finalized the transaction in 2025.
The divestiture of the Group Health business is projected to yield a financial book gain of around $500 million and marks an effort of Allstate to sustain its strong record of returning value to shareholders.
Meanwhile, out of the recent divestiture, Nationwide is expected to benefit from a diversified portfolio and enhanced capacity to offer stop-loss insurance solutions to small businesses.
The recent sale is part of Allstate’s strategy to divest its Health and Benefits business, for which it made an announcement to explore opportunities in November 2023. The unit comprises employer voluntary benefits, group health and individual health businesses.
In April 2025, ALL closed the divestiture of its Employer Voluntary Benefits business to StanCorp Financial Group, Inc. The leftover Individual Health business will either be retained by Allstate or merged with another company. The combined proceeds derived from selling the Group Health and Employer Voluntary Benefits businesses stand at $3.25 billion.
Motive of ALL Behind Such Divestitures
Allstate strategically engages in divestitures to reallocate capital away from businesses that generate lower returns and limited growth prospects. This approach enables the company to reinvest more effectively in its core operational areas. Consequently, such divestiture announcements underscore Allstate’s commitment to strengthening its market presence in the Property-Liability segment as well as expanding its suite of protection service offerings.
Premiums earned in the Property-Liability segment benefited from the back of rate increases in the first quarter of 2025. Meanwhile, higher contributions from Allstate Protection Plans and Arity drove the performance of the Protection Services unit. Strong distribution relationships and product suite led to the growth of Allstate Protection Plans, while improved lead sales propel Arity revenues.
Allstate’s Price Performance & Zacks Rank
Shares of Allstate have gained 25.6% in the past year compared with the industry’s 19.8% growth. ALL currently carries a Zacks Rank #2 (Buy).
Palomar’s earnings surpassed estimates in each of the last four quarters, the average surprise being 16.42%. The Zacks Consensus Estimate for PLMR’s 2025 earnings indicates a rise of 39.3% while the same for revenues implies an improvement of 42.5% from the respective 2024 figures. The consensus mark for PLMR’s 2025 earnings has moved 0.4% north in the past 30 days.
The bottom line of Heritage Insurance beat estimates in each of the trailing four quarters, the average surprise being 363.17%. The Zacks Consensus Estimate for HRTG’s 2025 earnings indicates a rise of 61.7% while the same for revenues implies an improvement of 4.6% from the respective 2024 figures. The consensus mark for HRTG’s 2025 earnings has moved 33.7% north in the past 60 days.
Horace Mann’s earnings surpassed estimates in three of the last four quarters and matched the mark once, the average surprise being 24.09%. The Zacks Consensus Estimate for HMN’s 2025 earnings indicates a rise of 26.1% while the same for revenues implies an improvement of 6.6% from the respective 2024 figures. The consensus mark for HMN’s 2025 earnings has moved 5.5% north in the past 60 days.
Shares of Palomar, Heritage Insurance and Horace Mann have gained 72.8%, 242.7% and 30.2%, respectively, in the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Allstate Finalizes Group Health Divestiture for $1.25 Bn
Key Takeaways
The Allstate Corporation (ALL - Free Report) recently closed the sale of its Group Health business to Nationwide for a total consideration of $1.25 billion. ALL initially announced its intention to divest this business in January 2025, and as anticipated, successfully finalized the transaction in 2025.
The divestiture of the Group Health business is projected to yield a financial book gain of around $500 million and marks an effort of Allstate to sustain its strong record of returning value to shareholders.
Meanwhile, out of the recent divestiture, Nationwide is expected to benefit from a diversified portfolio and enhanced capacity to offer stop-loss insurance solutions to small businesses.
The recent sale is part of Allstate’s strategy to divest its Health and Benefits business, for which it made an announcement to explore opportunities in November 2023. The unit comprises employer voluntary benefits, group health and individual health businesses.
In April 2025, ALL closed the divestiture of its Employer Voluntary Benefits business to StanCorp Financial Group, Inc. The leftover Individual Health business will either be retained by Allstate or merged with another company. The combined proceeds derived from selling the Group Health and Employer Voluntary Benefits businesses stand at $3.25 billion.
Motive of ALL Behind Such Divestitures
Allstate strategically engages in divestitures to reallocate capital away from businesses that generate lower returns and limited growth prospects. This approach enables the company to reinvest more effectively in its core operational areas. Consequently, such divestiture announcements underscore Allstate’s commitment to strengthening its market presence in the Property-Liability segment as well as expanding its suite of protection service offerings.
Premiums earned in the Property-Liability segment benefited from the back of rate increases in the first quarter of 2025. Meanwhile, higher contributions from Allstate Protection Plans and Arity drove the performance of the Protection Services unit. Strong distribution relationships and product suite led to the growth of Allstate Protection Plans, while improved lead sales propel Arity revenues.
Allstate’s Price Performance & Zacks Rank
Shares of Allstate have gained 25.6% in the past year compared with the industry’s 19.8% growth. ALL currently carries a Zacks Rank #2 (Buy).
Image Source: Zacks Investment Research
Other Stocks to Consider
Some other top-ranked stocks in the insurance space are Palomar Holdings, Inc. (PLMR - Free Report) , Heritage Insurance Holdings, Inc. (HRTG - Free Report) and Horace Mann Educators Corporation (HMN - Free Report) , each currently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Palomar’s earnings surpassed estimates in each of the last four quarters, the average surprise being 16.42%. The Zacks Consensus Estimate for PLMR’s 2025 earnings indicates a rise of 39.3% while the same for revenues implies an improvement of 42.5% from the respective 2024 figures. The consensus mark for PLMR’s 2025 earnings has moved 0.4% north in the past 30 days.
The bottom line of Heritage Insurance beat estimates in each of the trailing four quarters, the average surprise being 363.17%. The Zacks Consensus Estimate for HRTG’s 2025 earnings indicates a rise of 61.7% while the same for revenues implies an improvement of 4.6% from the respective 2024 figures. The consensus mark for HRTG’s 2025 earnings has moved 33.7% north in the past 60 days.
Horace Mann’s earnings surpassed estimates in three of the last four quarters and matched the mark once, the average surprise being 24.09%. The Zacks Consensus Estimate for HMN’s 2025 earnings indicates a rise of 26.1% while the same for revenues implies an improvement of 6.6% from the respective 2024 figures. The consensus mark for HMN’s 2025 earnings has moved 5.5% north in the past 60 days.
Shares of Palomar, Heritage Insurance and Horace Mann have gained 72.8%, 242.7% and 30.2%, respectively, in the past year.